Cancer molecular diagnostics
10% of all cancers are hereditary. Detection of cancer risk (detection of cancer susceptibility) and protective monitoring according to this risk enable the disease to be controlled very early. It is also used for the detection of mutations known to cause cancers, diagnosis of cancer, treatment and prognosis. Cancers where the next generation of sequencing technology is often used;
Solid tumors; brain, colon, lung, kidney, breast, thyroid, ovary, stomach, prostate, breast etc.
Hematological cancers; Lymphoma, Acute Myeloid, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myeloproliferative Neoplasia (MPN).
POLGEN uses a new generation of sequencing systems and bioinformatics analysis capacity for genetic screening of cancer panels.
This post is also available in: Turkish
